Cairo - Mubasher: IMS Health on Sunday reported that Ibnsina Pharma’s market share increased to 19.24% in 2017 from 16.86% a year earlier, boosted by higher sales
Egypt's largest drug distributor said that its market share rose by 2.38 points in 2017, beating expectations, according to the company’s statement on the Egyptian Exchange (EGX).
During 2017, the company’s sales grew 20.02%, exceeding aggregate growth rate of drug sales in the North African nation.
